Mouse models of Chlamydia pneumoniae infection and atherosclerosis

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Campbell, L A ^a   Kuo, C C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; ROXITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; INOCULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032740446     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70290-5     Document Type: Conference Paper

References (16)

1. Yang Y-S, Cummings PK, Patton DL, et al. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J Infect Dis 1995;171:736-8.
2. Moazed TC, Kuo CC, Grayston JT, et al. An experimental rabbit model of Chlamydia pneumoniae infection. Am J Pathol 1996;148:667-76.
3. Moazed TC, Kuo C-C, Grayston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
4. Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
5. Piedrahita JA, Zhang SH, Hagaman JR, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992;89:4471-5.
6. Godzik K, O'Brien ER, Wang S-W, et al. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995;33:2411-4.
7. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20.
8. Moazed TC, Kuo CC, Grayston JT, et al. Systemic dissemination of C pneumoniae infection via macrophages. J Infect Dis 1998;177:132-5.
9. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular and non-cardiovascular tissues: evaluation of the innocent bystander hypothesis. Am J Pathol 1997;150:1785-90.
10. Moazed TC, Campbell LA, Rosenfeld ME, et al. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein (ApoE)-deficient mice. In: Stephens RS, Byrne GI, Christiansen G, et al, editors. Chlamydial Infections, 1998: Proceedings of the Ninth International Symposium on Human Chlamydial Infections. University of California Printing Services, Berkeley, Calif, May 1998, p. 426-9.
11. Laitinen K, Laurila A, Pyhala L, et al. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 1997;65:4832-5.
12. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997;35:48-52.
13. Malinverni R, Kuo C-C, Campbell LA, et al. Experimental Chlamydia pneumoniae (TWAR) pneumonitis: effect of 2 antibiotic regimens on the course and persistence of infection. Antimicrob Agents Chemother 1995;39:45-9.
14. Campbell LA, Moazed TC, Kuo C-C, et al. Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolaemic mice. Clin Microbiol Infect 1998;4(suppl 4): S23-32.
15. Malinverni R, Kuo C-C, Campbell LA, et al. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis 1995;172:593-4.
16. Laitinen K, Laurila AL, Leinonen M, et al. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun 1996;64:1488-90.